Cite
HARVARD Citation
Tavera, L. et al. (n.d.). BLU-945 or BLU-701 as single agents versus their combination with osimertinib in EGFR L858R driven tumor models. European journal of cancer. pp. S63-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tavera, L. et al. (n.d.). BLU-945 or BLU-701 as single agents versus their combination with osimertinib in EGFR L858R driven tumor models. European journal of cancer. pp. S63-. [Online].